Endothelial cell line choices and their primary-cell alternatives

Deciding between primary cells and a line

1. Ask whether the property survives immortalisation. Immortalisation alters cell cycle control and frequently alters differentiation, barrier function and responsiveness. If your readout is one of those, the line may not show it. If your readout is a signalling event or a transport process that is preserved, the line is the practical choice.
2. Account for donor variability. Primary cells differ between donors, which is a nuisance in a mechanism experiment and the whole point in a study about population variation. Decide which of those you are doing, and where donors matter, use several and report them.
3. Respect the tissue bed. Cells from different vascular beds and different tissues differ substantially in marker expression, barrier tightness and response. A line from one bed is not a general model of that cell type, and the bed belongs in the description.
4. Check what the line retains, in your own hands. Suppliers state which markers and functions a line retains, usually at low passage under their conditions. Confirm the ones your conclusion depends on in your own culture, at the passage you use, before the line becomes the basis of a project.
5. Consider a derived model where the question is genetic. Where the question concerns a specific genotype, a differentiated stem-cell-derived model or a line edited at the locus of interest answers it more directly than any catalogue line. Both are slower and more expensive, and both remove the argument about whether the model carries the variant.

Barrier function is the usual casualty

Immortalised barrier-forming cells commonly form a weaker barrier than their primary counterparts, and the difference is largest in exactly the tissues where barrier work is most interesting. A line chosen for convenience in a barrier experiment can produce permeability results that no primary system reproduces.

If the readout is barrier integrity, establish what the line achieves under your conditions and say so, or use primary cells and accept the limits on numbers and lifespan. Reporting the absolute value rather than a relative change is what lets a reader judge the model.

Differentiated models from stem cells

Cells differentiated from induced pluripotent stem cells carry the donor's genotype and can be produced in quantity, which makes them attractive for tissues where primary cells are scarce. They are also frequently immature compared with adult tissue, and the maturation protocol matters as much as the starting material.

Treat the differentiation protocol as part of the model, characterise the resulting cells against the markers your conclusion depends on, and expect variability between differentiation batches. These are powerful models that reward being described precisely.

Edited lines and isogenic comparison

A line in which one locus has been altered against an otherwise identical background is the cleanest comparison available in cell culture, because everything except the variable is shared. Making one is a project in itself and buying one, where it exists, is usually cheaper.

Confirm the edit, keep the parental line banked alongside and use both in every experiment. An edited line compared with a different laboratory's parental stock loses most of what the edit was for.

Human primary hepatocytes and primary hepatocytes generally

Primary hepatocytes are the reference system for hepatic metabolism because they retain the enzyme complement a cell line has lost, and the price of that is their behaviour in culture: they attach and then dedifferentiate over days, losing cytochrome activity unless the format supports them. Human lots come with donor demographics and an activity panel, and lot-to-lot variability is real enough that a study fixes the lot. Cryopreserved cells plate at a lower efficiency than fresh; sandwich or spheroid formats extend useful life from days to weeks where a long incubation is needed.

Lymphoblastoid cell lines, and what they are for

An Epstein-Barr virus transformed B cell line is the standard way to make an immortal, renewable source of a donor's genome, which is why biobanks hold thousands of them for genetics. They grow in suspension, are easy to keep and are a poor model of a B cell, since transformation changes expression profoundly. For genotype work that does not matter; for functional immunology it matters entirely, and the line's consent and provenance travel with it as a condition of use.

ipsc cell lines, and what arrives with one

An induced pluripotent line arrives as a vial with a characterisation package, and the package is the product: identity against the donor, a pluripotency panel, karyotype or array-based genomic integrity, mycoplasma and sterility, and the culture system it was adapted to. Feeder-free and feeder-dependent lines are not interchangeable without adaptation, passage number matters because karyotype drifts, and the differentiation protocol is what decides whether the cells you actually use resemble the tissue you are studying.

cd34 cells, and what a progenitor preparation is

CD34 marks haematopoietic progenitors, and cells sold under that name are an enriched primary population rather than a line: mobilised peripheral blood, cord blood or marrow, selected on the marker, with a purity figure, a viability figure and a colony-forming assay behind them. All three belong in the method, because a selection at eighty per cent purity and one at ninety-eight behave differently in a differentiation experiment. They are donor material, so consent and traceability travel with the vial, and expansion changes the phenotype quickly.

mesenchymal stem cell markers, and the criteria behind them

Mesenchymal stromal cells are defined by a set of criteria rather than one marker: adherence to plastic, positive surface expression of a small panel including CD73, CD90 and CD105, absence of haematopoietic and endothelial markers, and demonstrated differentiation into bone, fat and cartilage lineages. So a flow panel alone does not identify them, and a supplier's certificate should carry both the panel and the differentiation evidence. Passage number matters because potency and marker profile both drift.

bronchial epithelial cells and the culture that differentiates them

bronchial epithelial cells are bought as primary cells and only become an airway model at an air liquid interface, where over weeks they form cilia, goblet cells and a barrier, so the culture format rather than the vial is what produces the phenotype. Transepithelial resistance and a differentiation marker panel are the acceptance checks, and every lot is a donor.

Common questions

Primary cells or an immortalised line?

It depends on whether your readout survives immortalisation. Cell cycle control, differentiation and barrier function commonly do not; many signalling and transport processes do. Decide on the specific readout rather than on the class of model.

Is one endothelial cell line a general model?

No. Cells from different vascular beds differ in markers, barrier tightness and response, so the bed belongs in the description and a line from one bed does not stand for the rest.

When is an edited line worth the cost?

When the conclusion depends on one genetic difference. An isogenic pair shares everything except the variable, which is the cleanest comparison available; buy one where it exists rather than making it.

Browse by service class

• Compare Gene synthesis on advertised prices